ID: ALA2418889

Max Phase: Preclinical

Molecular Formula: C20H12BrF2N3O5S

Molecular Weight: 524.30

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=[N+]([O-])c1ccc(OCc2nc3ccc(Br)cc3n2S(=O)(=O)c2cc(F)ccc2F)cc1

Standard InChI:  InChI=1S/C20H12BrF2N3O5S/c21-12-1-8-17-18(9-12)25(32(29,30)19-10-13(22)2-7-16(19)23)20(24-17)11-31-15-5-3-14(4-6-15)26(27)28/h1-10H,11H2

Standard InChI Key:  CVBSAFPULPUGGM-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 524.30

Molecular Weight (Monoisotopic): 522.9649

AlogP: 4.80

#Rotatable Bonds: 6

Polar Surface Area: 104.33

Molecular Species: NEUTRAL

HBA: 7

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa: 1.22

CX LogP: 4.82

CX LogD: 4.82

Aromatic Rings: 4

Heavy Atoms: 32

QED Weighted: 0.27

Np Likeness Score: -1.93

References

1. Ranjith PK, Rajeesh P, Haridas KR, Susanta NK, Row TN, Rishikesan R, Kumari NS..  (2013)  Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents.,  23  (18): [PMID:23942420] [10.1016/j.bmcl.2013.06.072]

Source

Source(1):

• Scientific Literature